Effects of cardiopulmonary bypass and cardioplegia on regional and global cardiac actions of halothane in dogs.
Cardiopulmonary bypass (CPB) with aortic cross-clamping represents a controlled period of global cardiac ischemia. We hypothesized that CPB (asanguineous prime), with aortic cross-clamping and repeated cardioplegia, alters myocardial function, which would be manifested as an exaggerated myocardial depression caused by halothane after CPB. In nine dogs anesthetized with fentanyl and midazolam, halothane dose-response curves (0.0%-2.0%) were compared before and after CPB. A reduced mean arterial blood pressure (46.4 +/- 3.7 vs 85.8 +/- 5.9 mm Hg), associated with a marked hemodilution (hematocrit, 19% +/- 1% vs 41% +/- 2%), was observed after CPB. Cardiac output and systolic shortening were not significantly different after versus before CPB during fentanyl-midazolam anesthesia. Normalized to fentanyl-midazolam hemodynamics, halothane dose-response curves before and after CPB were identical for all variables except cardiac output, where halothane caused a slight but statistically significantly more pronounced decrease after CPB compared with before CPB. The effect of halothane on left ventricular function, therefore, is relatively unaffected by CPB with cardioplegia.
Spahn
D R
DR
Department of Anesthesiology, Duke University, Durham, North Carolina.
Smith
L R
LR
Hu
W C
WC
McRae
R L
RL
Leone
B J
BJ
D000818:Animals; D002315:Cardiopulmonary Bypass; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D005283:Fentanyl / Q000494:pharmacology; D006221:Halothane / Q000494:pharmacology*; D006324:Heart Arrest, Induced; D006439:Hemodynamics / Q000187:drug effects*; D008874:Midazolam / Q000494:pharmacology
D008874:Midazolam; D005283:Fentanyl; D006221:Halothane